Inhibitor development as switching full-lengthrecombinant FVIII to B-domain deleted recombinantFVIII in previously treated patients with hemophilia A:Taiwan’s experience

Chia-Yau Chang, S-H Chen, G-C Yeh, C-H Tsai , J-R Tsai, Y-L Liu

研究成果: 雜誌貢獻特刊同行評審

指紋

深入研究「Inhibitor development as switching full-lengthrecombinant FVIII to B-domain deleted recombinantFVIII in previously treated patients with hemophilia A:Taiwan’s experience」主題。共同形成了獨特的指紋。

Medicine & Life Sciences